EP0970186A4 - SPOoJ2 FROM STAPHYLOCOCCUS AUREUS - Google Patents

SPOoJ2 FROM STAPHYLOCOCCUS AUREUS

Info

Publication number
EP0970186A4
EP0970186A4 EP98943538A EP98943538A EP0970186A4 EP 0970186 A4 EP0970186 A4 EP 0970186A4 EP 98943538 A EP98943538 A EP 98943538A EP 98943538 A EP98943538 A EP 98943538A EP 0970186 A4 EP0970186 A4 EP 0970186A4
Authority
EP
European Patent Office
Prior art keywords
spooj2
staphylococcus aureus
aureus
staphylococcus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98943538A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP0970186A1 (en
Inventor
Martin K R Burnham
Andrew Fosberry
John E Hodgson
Elizabeth J Lawlor
Martin Rosenberg
Judith Ward
Deborah D Jaworski
Min Wang
Lisa K Shilling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/042,771 external-priority patent/US6080729A/en
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0970186A1 publication Critical patent/EP0970186A1/en
Publication of EP0970186A4 publication Critical patent/EP0970186A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP98943538A 1997-09-04 1998-09-04 SPOoJ2 FROM STAPHYLOCOCCUS AUREUS Withdrawn EP0970186A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5750997P 1997-09-04 1997-09-04
US57509P 1997-09-04
US42771 1998-03-17
US09/042,771 US6080729A (en) 1998-03-17 1998-03-17 Spo0J2 of Staphylococcus aureus
PCT/US1998/018365 WO1999011753A1 (en) 1997-09-04 1998-09-04 SpoOJ2 OF STAPHYLOCOCCUS AUREUS

Publications (2)

Publication Number Publication Date
EP0970186A1 EP0970186A1 (en) 2000-01-12
EP0970186A4 true EP0970186A4 (en) 2002-04-03

Family

ID=26719605

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98943538A Withdrawn EP0970186A4 (en) 1997-09-04 1998-09-04 SPOoJ2 FROM STAPHYLOCOCCUS AUREUS

Country Status (3)

Country Link
EP (1) EP0970186A4 (ja)
JP (1) JP2002511768A (ja)
WO (1) WO1999011753A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080729A (en) * 1998-03-17 2000-06-27 Smithkline Beecham Corporation Spo0J2 of Staphylococcus aureus

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0786519A2 (en) * 1996-01-05 1997-07-30 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and sequences
EP0841394A2 (en) * 1996-09-24 1998-05-13 Smithkline Beecham Corporation Staphylococcus aureus polynucleotides, polypeptides and their uses

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0786519A2 (en) * 1996-01-05 1997-07-30 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and sequences
EP0841394A2 (en) * 1996-09-24 1998-05-13 Smithkline Beecham Corporation Staphylococcus aureus polynucleotides, polypeptides and their uses

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EBI; 1 August 1992 (1992-08-01), OGASAWARA ET AL.: "SPO0J, Stage 0 sporulation protein J", XP002188359 *
DATABASE EMBL EBI; 1 October 1994 (1994-10-01), OGASAWARA ET AL.: "YYAA, Hypothetical 32.8 kDa protein in SPO0J-GIDB intergenic region", XP002188358 *
DATABASE EMBL EBI; 7 November 1991 (1991-11-07), OGASAWARA: "B.subtilis genes rpmH, rnpA, 50kd, gidA and gidB", XP002160456 *
See also references of WO9911753A1 *

Also Published As

Publication number Publication date
JP2002511768A (ja) 2002-04-16
EP0970186A1 (en) 2000-01-12
WO1999011753A1 (en) 1999-03-11

Similar Documents

Publication Publication Date Title
AU8258698A (en) Isoquinoline-indole compounds as antimicrobial agents
HK1016885A1 (en) Antimicrobial caries-detecting composition
IL127258A0 (en) Antimicrobial compositions
HK1028737A1 (en) Novel antibacterial agents
PL340254A1 (en) Derivatives of pleuromutillin as antimicrobial agents
GB2354168B (en) Antimicrobial agents
ZA988237B (en) 8a-Azalides as veterinary antimicrobial agents
EP1109911A4 (en) STAPHYLOCOCCUS AUREUS GENES AND ASSOCIATED POLYPEPTIDES
EP0961615A4 (en) ANTIMICROBIAL AGENT
AU3307399A (en) Novel antibacterial agents
EP1011689A4 (en) 9a-AZALIDES USED AS VETERINARY ANTIMICROBIAL AGENTS
HUP0103711A3 (en) Novel antimicrobial compounds
HUP0003845A3 (en) Use of 8a-azalides as antimicrobial agents
GB9407869D0 (en) Antimicrobial compounds
ZA988399B (en) Antimicrobial composition
EP0970186A4 (en) SPOoJ2 FROM STAPHYLOCOCCUS AUREUS
HUP0002920A3 (en) Therapy for staphylococcus aureus
AU3168899A (en) Antibacterial agents
AU5582799A (en) Staphylococcus aureus polypeptides
AU6180296A (en) Triphenylalkyl antimicrobial agents
PL338671A1 (en) Treatment of staphylococcus aureus infections
GB2385790B (en) Antimicrobial agents
GB9716730D0 (en) Antimicrobial composition
GB9721821D0 (en) Antibacterial ETC agents
ZA988238B (en) 9a-Azalides as veterinary antimicrobial agents

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990913

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE DK FR GB IT LI NL

18W Application withdrawn

Withdrawal date: 20020205

A4 Supplementary search report drawn up and despatched

Effective date: 20020219

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE DK FR GB IT LI NL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

R18W Application withdrawn (corrected)

Effective date: 20020205